Info
Insider Ownership

Insider Trading & Ownership of Garry E. Menzel

Location: San Diego, CA
Summary: The estimated net worth of Garry E. Menzel is at least $50,513 dollars as of 12 Jun 2025. Garry E. Menzel is the Director of Adaptimmune Therapeutics PLC and owns shares of Adaptimmune Therapeutics PLC (ADAP) stock worth about $50.5K.
Signature: /s/ Brent Hatzis-Schoch, Attorney-in-Fact
All Insider Reports: All Insider Reports

Notify me when Garry E. Menzel files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Garry E. Menzel

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
ADAP	Adaptimmune Therapeutics PLC	Director	$50,513			01 Jul 2024
BDTX	Black Diamond Therapeutics, Inc.	Director				12 Jun 2025
STOK	Stoke Therapeutics, Inc.	Director				03 Jun 2025
TCRR	TCR2 THERAPEUTICS INC.	President and CEO, Director				01 Jun 2023

Insider Transactions Reported by Garry E. Menzel:

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.